David Clair | executive |
Charles Kummeth | executive |
Kim Kelderman | executive |
James Hippel | executive |
Puneet Souda | analyst |
Jacob Johnson | analyst |
Daniel Arias | analyst |
Patrick Donnelly | analyst |
Daniel Leonard | analyst |
Matthew Larew | analyst |
Catherine Ramsey | analyst |
Alexander Nowak | analyst |
Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2024. [Operator Instructions] I would now like to turn the call over to David Clair, Bio-Techne's Vice President of Investor Relations. Thank you.
You may begin.
Good morning, and thank you for joining us.